Plain-English translation of NCT06705335 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying special proteins called convertases that may play a role in pancreatic cancer. By collecting small tumor samples (taken during your routine surgery or biopsy) and blood samples from patients like you, they hope to learn how these proteins affect the disease and how well treatments work. This research aims to find new ways to predict which treatments will help individual patients and may lead to better therapies in the future.
Pancreatic cancer is very difficult to treat, and doctors currently don't have good ways to predict which patients will respond to specific treatments. By studying these protein patterns in tumor tissue, researchers hope to develop better tools to personalize treatment and improve survival rates for people with this disease.
You likely qualify if…
You likely don't qualify if…
If you join, your participation is relatively straightforward. A small sample of your tumor will be collected during your already-planned surgery or biopsy, and a blood sample will be drawn on the same day. After that, you'll receive standard cancer care as usual. For the next 2 years, the research team will check in periodically to track how you're doing, whether your cancer has progressed, and your overall health status — this happens through routine clinical visits you'd likely be having anyway.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
France
Sponsor
Institut Bergonié
Enrollment target
~50 participants
Started
March 2026
Primary completion
January 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Simon PERNOT, Dr
Institut Bergonié
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.